Safety and tolerability of enteric-coated mycophenolate sodium in renal transplant patients with GI intolerance
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2008
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Novartis
- 23 Jan 2008 Status changed from recruiting to completed.
- 05 Dec 2005 New trial record.